Anand Mehra

Insider Reports History

Location
3000 Sand Hill Road, 4 250, Menlo Park, CA
Signature
/s/ Matthew Rothman, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anand Mehra:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aclaris Therapeutics, Inc. Director Common Stock 715K $1.09M $1.53 Jun 6, 2025 Direct
Merus N.V. Director Share Option (right to buy) 13.2K $120K $13.52 May 22, 2025 Direct
Aclaris Therapeutics, Inc. Director Restricted Stock Units 0 $4.94K $1.03 Jun 6, 2025 Direct
Aclaris Therapeutics, Inc. Director Stock Option (Right to Buy) 42.4K Jun 5, 2025 Direct

Insider Reports Filed by Anand Mehra

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ACRS Aclaris Therapeutics, Inc. Jun 5, 2025 4 $0 4 Jun 9, 2025 Director
MRUS Merus N.V. May 22, 2025 1 $0 4 May 27, 2025 Director
ACRS Aclaris Therapeutics, Inc. Nov 19, 2024 1 $1.5M 4 Nov 20, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 6, 2024 2 $0 4 Jun 10, 2024 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2024 2 $0 4 Jun 4, 2024 Director
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 Director
MRUS Merus N.V. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
ACRS Aclaris Therapeutics, Inc. Jun 1, 2023 4 $0 4 Jun 5, 2023 Director
ACRS Aclaris Therapeutics, Inc. Jun 2, 2022 4 $0 4 Jun 6, 2022 Director
MRUS Merus N.V. May 31, 2022 1 $0 4 Jun 2, 2022 Director
ACRS Aclaris Therapeutics, Inc. Jun 3, 2021 2 $0 4 Jun 4, 2021 Director
MRUS Merus N.V. May 28, 2021 1 $0 4 Jun 2, 2021 Director